Insights On Manufacturing Logistics

  1. Annex 1 FAQs: What Was The Biggest Challenge With EU GMP Annex 1? 5/11/2026

    Translating EU GMP Annex 1 into consistent site-level practice is where most manufacturers struggle. Hear why the global-to-local execution gap remains the industry's biggest compliance challenge and what it takes to close it.

  2. Annex 1 FAQs: How Is Behavior Changing As A Result Of EU GMP Annex 1? 5/11/2026

    EU GMP Annex 1 is driving meaningful changes in how teams behave inside cleanrooms. Understand what contamination awareness really means in practice and how to build a culture where speaking up is standard.

  3. Annex 1 FAQs: How Do You Understand Risk Regarding Contamination Control? 5/11/2026

    True Annex 1 compliance requires a facility-wide contamination-control culture. Discover how rigorous risk awareness shapes behavior at every touchpoint across a manufacturing environment.

  4. Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design 5/6/2026

    Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.

  5. Successfully Navigating Opportunities With On-Body Delivery Systems 4/23/2026

    Drawing on insights from the global regulatory landscape, industry trends, and direct feedback from customers, Dr. Di Wu addresses some of the most frequently asked questions about on-body delivery system requirements.

  6. Implementing Medium And High-Volume Drug Handling And Packaging Programs 4/23/2026

    Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.

  7. West Vantage™ Goes Beyond Contract Manufacturing 4/23/2026

    Successfully advancing a drug-delivery device to market demands more than technical expertise; it requires coordinated execution, regulatory insight, and the ability to scale without disruption.

  8. Strategic Supply Chain Leadership: Driving Biopharma Growth 4/22/2026

    Amid a volatile pharma supply chain, strategic sourcing is now critical. Prioritizing your raw material supply ensures operational continuity, consistent performance, compliance, and on-time delivery.

  9. Syringe–Cartridge Filling Line In Action 4/21/2026

    Designed for medium‑ to high‑volume ISO syringes and cartridges, this high‑speed filling line delivers tight manufacturing control, supports larger batches, and meets growing biologics demand.

  10. Biopharma Supply, Reimagined: Regional, Resilient Manufacturing 4/1/2026

    Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.